Citation: V. Berge et al., CLUSTERIN AND THE TERMINAL COMPLEMENT PATHWAY SYNTHESIZED BY HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS ARE CLOSELY LINKED WHEN DETECTED ON COCULTURED AGAROSE BEADS, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 105(1), 1997, pp. 17-24
Citation: V. Berge et al., VITRONECTIN MODULATES THE EXPRESSION OF COMPLEMENT COMPONENTS OF THE TERMINAL PATHWAY SYNTHESIZED BY HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLSIN-VITRO, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 104(7-8), 1996, pp. 523-530
Citation: V. Berge et al., INTERLUEKIN-1-ALPHA, INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA INCREASE THE SYNTHESIS AND EXPRESSION OF THE FUNCTIONAL ALTERNATIVE AND TERMINAL COMPLEMENT PATHWAYS BY HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLSIN-VITRO, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 104(3), 1996, pp. 213-219
Citation: V. Berge et al., COMPLICATIONS OF INVASIVE, URODYNAMIC EXAMINATIONS AND PROSTATE BIOPSIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA, Scandinavian journal of urology and nephrology, 1995, pp. 95-98
Citation: V. Berge et al., EFFECT OF GAMMA-INTERFERON ON THE SYNTHESIS OF THE FUNCTIONAL ALTERNATIVE AND TERMINAL COMPLEMENT PATHWAYS BY HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS IN-VITRO, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 102(7), 1994, pp. 554-558
Citation: E. Johnson et al., FORMATION OF THE TERMINAL COMPLEMENT COMPLEX ON AGAROSE BEADS - FURTHER EVIDENCE THAT VITRONECTIN (COMPLEMENT S-PROTEIN) INHIBITS C9 POLYMERIZATION, Scandinavian journal of immunology, 39(3), 1994, pp. 281-285